Position in CCCC
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$5,419,754
+$4,921,425 QoQ
Shares Held
1,160,547
+512.5% QoQ
Ownership
0.943%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#27
of 147 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 99%
Shared 1%
None 0%
Common Shares in CCCC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NORTHERN TRUST CORP holds $7,813,607,781 across 424 Biotechnology names. CCCC ranks #157 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,486,478 | $1,235,108,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
916,467 | $571,453,829 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
886,900 | $266,983,504 | |
| 4 | RPRX |
Royalty Pharma plc
|
4,718,859 | $264,586,419 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
1,117,110 | $209,212,357 | |
| 6 | MRNA |
Moderna, Inc.
|
2,985,329 | $209,062,587 | |
| 7 | INCY |
Incyte Corp
|
1,761,966 | $199,736,460 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,647,345 | $140,337,319 |
All Filings in CCCC
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,419,754 | 1,160,547 | Shares | Other | 2026-08-13 | |
| 2026-03-31 | $498,329 | 189,479 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $317,454 | 166,207 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $307,067 | 138,319 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $199,731 | 139,673 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $799,628 | 499,768 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $1,782,154 | 495,043 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $2,791,973 | 489,820 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $829,626 | 179,573 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $887,898 | 108,678 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $614,024 | 108,677 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $169,244 | 90,992 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $250,684 | 91,158 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $1,207,655 | 384,604 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $2,354,288 | 399,032 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $3,349,988 | 381,983 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,793,719 | 370,520 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $8,473,093 | 349,262 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $11,646,610 | 361,696 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $16,261,418 | 363,953 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $11,479,859 | 303,379 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $4,404,620 | 119,076 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $4,143,568 | 125,070 | Shares | Defined | 2021-02-11 | |
| No filing history on record for this holder in this stock. | ||||||